We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Oscar Health, Inc. (OSCR) Stock Sinks As Market Gains: Here's Why
Read MoreHide Full Article
Oscar Health, Inc. (OSCR - Free Report) closed the most recent trading day at $33.47, moving -2.48% from the previous trading session. The stock fell short of the S&P 500, which registered a gain of 0.33% for the day. Elsewhere, the Dow gained 1.08%, while the tech-heavy Nasdaq added 0.08%.
Coming into today, shares of the company had gained 6.12% in the past month. In that same time, the Finance sector lost 3.99%, while the S&P 500 gained 1.41%.
The investment community will be paying close attention to the earnings performance of Oscar Health, Inc. in its upcoming release. The company is slated to reveal its earnings on November 5, 2026. The company is predicted to post an EPS of -$0.11, indicating a 79.25% growth compared to the equivalent quarter last year. Alongside, our most recent consensus estimate is anticipating revenue of $4.72 billion, indicating a 58.14% upward movement from the same quarter last year.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $1.83 per share and revenue of $18.81 billion, indicating changes of +208.28% and +60.77%, respectively, compared to the previous year.
Investors might also notice recent changes to analyst estimates for Oscar Health, Inc. Such recent modifications usually signify the changing landscape of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, there's been a 18.79% rise in the Zacks Consensus EPS estimate. Oscar Health, Inc. is currently a Zacks Rank #1 (Strong Buy).
With respect to valuation, Oscar Health, Inc. is currently being traded at a Forward P/E ratio of 18.72. This denotes a premium relative to the industry average Forward P/E of 10.07.
Also, we should mention that OSCR has a PEG ratio of 0.38. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. Insurance - Multi line stocks are, on average, holding a PEG ratio of 0.94 based on yesterday's closing prices.
The Insurance - Multi line industry is part of the Finance sector. This industry, currently bearing a Zacks Industry Rank of 99, finds itself in the top 41% echelons of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
View the Zacks #1 Rank List
Image: Bigstock
Oscar Health, Inc. (OSCR) Stock Sinks As Market Gains: Here's Why
Oscar Health, Inc. (OSCR - Free Report) closed the most recent trading day at $33.47, moving -2.48% from the previous trading session. The stock fell short of the S&P 500, which registered a gain of 0.33% for the day. Elsewhere, the Dow gained 1.08%, while the tech-heavy Nasdaq added 0.08%.
Coming into today, shares of the company had gained 6.12% in the past month. In that same time, the Finance sector lost 3.99%, while the S&P 500 gained 1.41%.
The investment community will be paying close attention to the earnings performance of Oscar Health, Inc. in its upcoming release. The company is slated to reveal its earnings on November 5, 2026. The company is predicted to post an EPS of -$0.11, indicating a 79.25% growth compared to the equivalent quarter last year. Alongside, our most recent consensus estimate is anticipating revenue of $4.72 billion, indicating a 58.14% upward movement from the same quarter last year.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $1.83 per share and revenue of $18.81 billion, indicating changes of +208.28% and +60.77%, respectively, compared to the previous year.
Investors might also notice recent changes to analyst estimates for Oscar Health, Inc. Such recent modifications usually signify the changing landscape of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, there's been a 18.79% rise in the Zacks Consensus EPS estimate. Oscar Health, Inc. is currently a Zacks Rank #1 (Strong Buy).
With respect to valuation, Oscar Health, Inc. is currently being traded at a Forward P/E ratio of 18.72. This denotes a premium relative to the industry average Forward P/E of 10.07.
Also, we should mention that OSCR has a PEG ratio of 0.38. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. Insurance - Multi line stocks are, on average, holding a PEG ratio of 0.94 based on yesterday's closing prices.
The Insurance - Multi line industry is part of the Finance sector. This industry, currently bearing a Zacks Industry Rank of 99, finds itself in the top 41% echelons of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.